Evidence map›Paper›PMID 33460454›Full record

ArticleImmunology2021

The immunopeptidomes of two transmissible cancers and their host have a common, dominant peptide motif.

Annalisa Gastaldello, Sri H Ramarathinam, Alistair Bailey, Rachel Owen, Steven Turner, N Kontouli, Tim Elliott, Paul Skipp, Anthony W Purcell, Hannah V Siddle

Open access · hybridAbstract read
In one paragraph

Article in Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Annalisa GastaldelloSchool of Biological Sciences, University of Southampton, Southampton, UK.
Sri H RamarathinamDepartment of Biochemistry and Molecular Biology and the Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Alistair BaileyCentre for Cancer Immunology, University of Southampton, Southampton, UK.
Rachel OwenSchool of Biological Sciences, University of Southampton, Southampton, UK.
Steven TurnerCentre for Cancer Immunology, University of Southampton, Southampton, UK.
N KontouliCentre for Cancer Immunology, University of Southampton, Southampton, UK.
Tim ElliottCentre for Cancer Immunology, University of Southampton, Southampton, UK.
Paul SkippSchool of Biological Sciences, University of Southampton, Southampton, UK.
Anthony W PurcellDepartment of Biochemistry and Molecular Biology and the Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Hannah V SiddleSchool of Biological Sciences, University of Southampton, Southampton, UK.ORCID 0000-0003-2906-4385
University of Southampton · GBDiscovery Institute · US

Funding

Biotechnology and Biological Sciences Research Council BM/M012387/1Cancer Research UK A21998Cancer Research UK A28279
6 · The paper itself

Abstract

Transmissible cancers are malignant cells that can spread between individuals of a population, akin to both a parasite and a mobile graft. The survival of the Tasmanian devil, the largest remaining marsupial carnivore, is threatened by the remarkable emergence of two independent lineages of transmissible cancer, devil facial tumour (DFT) 1 and devil facial tumour 2 (DFT2). To aid the development of a vaccine and to interrogate how histocompatibility barriers can be overcome, we analysed the peptides bound to major histocompatibility complex class I (MHC-I) molecules from Tasmanian devil cells and representative cell lines of each transmissible cancer. Here, we show that DFT1 + IFN-γ and DFT2 cell lines express a restricted repertoire of MHC-I allotypes compared with fibroblast cells, potentially reducing the breadth of peptide presentation. Comparison of the peptidomes from DFT1 + IFNγ, DFT2 and host fibroblast cells demonstrates a dominant motif, despite differences in MHC-I allotypes between the cell lines, with preference for a hydrophobic leucine residue at position 3 and position Ω of peptides. DFT1 and DFT2 both present peptides derived from neural proteins, which reflects a shared cellular origin that could be exploited for vaccine design. These results suggest that polymorphisms in MHC-I molecules between tumours and host can be 'hidden' by a common peptide motif, providing the potential for permissive passage of infectious cells and demonstrating complexity in mammalian histocompatibility barriers.

Indexed as

Amino Acid MotifsAnimalsAntigen PresentationAntigens, NeoplasmCancer VaccinesCell Line, TumorFacial NeoplasmsHistocompatibilityHistocompatibility Antigens Class IImmunotherapyMarsupialiaNeoplastic Cells, CirculatingPeptidesPolymorphism, GeneticProtein BindingAntigens, NeoplasmCancer VaccinesHistocompatibility Antigens Class IPeptidescontagious cancerimmunopeptidomemarsupialMHCTasmanian devilTransmissible cancer

Identifiers

PMID33460454
PMCPMC8114214
OpenAlexW3124211131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.